Furthermore, some studies in cancer models suggest that N2 TANs are more prone to NETosis and that, reciprocally, NETosis skews neutrophils in the tumor microenvironment to an N2 phenotype, possibly by MMP9 activation of latent TGFb in the NET [57–59]. The gene discussed is MMP9; the disease is neoplasm.